Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas
Status:
Terminated
Trial end date:
2019-04-19
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if gemcitabine can enter pancreas cancer
cells, to measure the amount of it that may enter the cells, and for biomarker testing.
Biomarkers may be related to participant's reaction to the study drug.